4 0 4 VOLUME 22 | NUMBER 4 | APRIL 2016 nAture medicine Spasticity, a common debilitating complication in people with spinal cord injury (SCI), is characterized by a velocity-dependent increase in the tonic stretch reflex and spasms 1 . It is primarily attributed to a reduction in postsynaptic inhibition and an increase in the excitability of motoneurons below the lesion 2 . Although disinhibition is related to a dysregulation of chloride homeostasis 3 , the mechanisms that cause motoneuron hyperexcitability are not yet fully understood. In the healthy spinal cord, the excitability of motoneurons is set by brainstem-derived serotonin (5-hydroxytryptamine (5-HT)). The activation of 5-HT type 2 receptors (5-HT 2 ) facilitates voltage-gated persistent calcium and sodium currents 4,5 (persistent inward currents, or PICs). These PICs considerably amplify the activity of brief synaptic excitatory inputs, which enables sustained muscle contractions 6 . PICs are reduced early after SCI 7 as compared to those in healthy spinal cords, but slowly recover within weeks, leading to excessive motoneuron activity that is characterized by the plateau potentials associated with muscle spasms 8, 9 . The upregulation of Ca 2+ PICs in the chronic phase after the injury is due to the increased expression of 5-HT subtype 2C receptors (5-HT 2C ), which become constitutively active 10 . However, a major question that remains is how the Na + PIC (I NaP )-a key conductance of the locomotor network 11-14 that drives plateau potentials in motoneurons 15 -is upregulated. In adult rats, spinal cord neurons express mRNA encoding five α-subunits of sodium channels (Nav1.1, Nav1.2, Nav1.3, Nav1.6 and Nav1.7) 16 , but the main α-subunits in spinal motoneurons are Nav1.1 and Nav1.6 (ref. 17). We demonstrate here that the upregulation of I NaP after SCI is accompanied by a proteolytic cleavage of the α-subunit of Nav channels. We further show that calpains, a family of intracellular calcium-dependent cysteine proteases 18 , are responsible for the cleavage of Nav1.6 channels. Our results open new therapeutic avenues, given that blocking either I NaP or the activity of calpain reduces spasticity.
Spasticity, a common debilitating complication in people with spinal cord injury (SCI), is characterized by a velocity-dependent increase in the tonic stretch reflex and spasms 1 . It is primarily attributed to a reduction in postsynaptic inhibition and an increase in the excitability of motoneurons below the lesion 2 . Although disinhibition is related to a dysregulation of chloride homeostasis 3 , the mechanisms that cause motoneuron hyperexcitability are not yet fully understood. In the healthy spinal cord, the excitability of motoneurons is set by brainstem-derived serotonin (5-hydroxytryptamine (5-HT)). The activation of 5-HT type 2 receptors (5-HT 2 ) facilitates voltage-gated persistent calcium and sodium currents 4, 5 (persistent inward currents, or PICs). These PICs considerably amplify the activity of brief synaptic excitatory inputs, which enables sustained muscle contractions 6 . PICs are reduced early after SCI 7 as compared to those in healthy spinal cords, but slowly recover within weeks, leading to excessive motoneuron activity that is characterized by the plateau potentials associated with muscle spasms 8, 9 . The upregulation of Ca 2+ PICs in the chronic phase after the injury is due to the increased expression of 5-HT subtype 2C receptors (5-HT 2C ), which become constitutively active 10 . However, a major question that remains is how the Na + PIC (I NaP )-a key conductance of the locomotor network [11] [12] [13] [14] that drives plateau potentials in motoneurons 15 -is upregulated. In adult rats, spinal cord neurons express mRNA encoding five α-subunits of sodium channels (Nav1.1, Nav1.2, Nav1.3, Nav1.6 and Nav1.7) 16 , but the main α-subunits in spinal motoneurons are Nav1.1 and Nav1. 6 (ref. 17) . We demonstrate here that the upregulation of I NaP after SCI is accompanied by a proteolytic cleavage of the α-subunit of Nav channels. We further show that calpains, a family of intracellular calcium-dependent cysteine proteases 18 , are responsible for the cleavage of Nav1.6 channels. Our results open new therapeutic avenues, given that blocking either I NaP or the activity of calpain reduces spasticity.
RESULTS
Upregulation of Nav1.6 a-subunit expression after SCI We tested whether abnormal expression of Nav channels accounts for the upregulation of I NaP after SCI. To model SCI in rodents, we carried out a complete transection at the T8-T9 level in adult female rats to avoid regeneration of the supraspinal tracts. At 15 d, 30 d and 60 d after SCI or sham surgery, we performed immunohistochemistry in lumbar segments L4-L5 (caudal to the lesion) to analyze the expression of the two main Nav α-subunits that are present in motoneurons (Nav1.1 and Nav1. 6 (ref. 17) ). A pan-Nav antibody that recognizes all Nav1 isoforms strongly stained axon initial segments (AISs) of motoneurons in both sham-operated and SCI rats (Fig. 1a) . Although the Nav1.1 α-subunit was hardly detectable (Supplementary Fig. 1a ), Nav1.6-specific immunolabeling largely overlapped the pan-staining (Fig. 1a, middle and right) . The intensity of Nav immunostaining revealed by both the pan-Nav and the Nav1.6 antibodies was higher in motoneurons after SCI than in sham-operated controls as early as 15 d after SCI (P < 0.001; Fig. 1a-c) . Conversely, the Nav1.6-specific immunostaining in the AIS segments of Renshaw cells did not change after SCI (P > 0.05; Supplementary Fig. 1b,c) .
Calpain mediates proteolysis of Nav1.6 channels after SCI To confirm the changes in Nav expression after SCI, we performed western blots on the membrane fractions isolated from the lumbar spinal cord. The pan-Nav antibody revealed a prominent ~250-kDa band consistent with the full-length α-subunits of Nav 19 (Fig. 2a) . Although this band was unaffected by SCI, a distinct ~120-kDa band increased (P < 0.001; Fig. 2a,b) , such that the total amount of Nav channels at the membrane was higher in SCI samples than in shamoperated controls (P < 0.05; Fig. 2b ). In sham-operated rats 15-60 d after surgery, the ~120-kDa band represented a smaller proportion of total Nav protein relative to the ~250-kDa band (P < 0.001; Fig. 2c ), whereas in rats with SCI, the ~120-kDa and ~250-kDa bands were found to represent roughly equal proportions of total Nav protein (P > 0.05; Fig. 2c ). The expression of the neuronal microtubule element β-tubulin III, which was used as an internal control, did not change after SCI (Fig. 2b) .
We then investigated Nav proteolysis in adult rat spinal cord homogenates. In Ca 2+ -chelated saline (5 mM ethylenediaminetetraacetic acid (EDTA)), homogenates revealed a single ~250-kDa band (Fig. 2d, left  column) . The addition of calcium (10 mM) in homogenates generated a ~120-kDa second band similar to that observed in vivo after SCI (Fig. 2d, middle) , which suggests the contribution of a cytosolic Ca 2+ -dependent protease. A pretreatment of homogenates with MDL28170, a widely used calpain inhibitor 20, 21 , prevented the formation of this second band (Fig. 2d, right) . Conversely, the addition of calpain progressively and dose-dependently reduced the ~250-kDa band and increased the ~120-kDa band corresponding to the cleaved Pan-Nav Nav1. (f) Quantification of ~250-kDa and ~120-kDa bands relative to total Nav protein (0 U, n = 8; 0.5 U, n = 6; 1 U, n = 2; 2 U, n = 4; 3 U, n = 2; n replicates from four rats). ***P < 0.001, comparing ~250-kDa to ~120-kDa bands; two-way ANOVA, Bonferroni's post hoc test. (g) Pan-Nav immunoblot of HEK293 Nav1.6-expressing cells with or without calpain (1 U). (h) Quantification of ~250-kDa and ~120-kDa bands in calpain-treated culture, normalized to untreated culture (0 U, n = 4; 1 U, n = 6; n replicates from two cultures). **P < 0.01; Mann-Whitney test. Data are mean ± s.e.m. for all panels. (Fig. 2e,f) . MDL28170 blocked the calpain-induced cleavage ( Fig. 2e , right two bands). Similar results were obtained for Nav1.6 channels expressed in HEK293 cells. The application of calpain reduced the native ~250-kDa band to generate a lower molecular weight band of ~120 kDa (P < 0.01; Fig. 2g,h ). In sum, α-subunits of Nav channels in the adult rat spinal cord, and specifically the Nav1.6 isoform that is prominently expressed in motoneurons, are substrates of calpains.
Calpain is involved in SCI-induced potentiation of I NaP
To further examine the role of calpain in the SCI-induced cleavage of Nav α-subunits, we employed a SCI model in neonatal rats that, when compared to the adult model, more readily enables patchclamp recordings to be obtained from motoneurons in acute spinal cord slices in vitro. SCI performed at birth induced a cleavage of Nav channels similar to what was observed after SCI in adults (P < 0.001; Fig. 3a-c) . Intraperitoneal (i.p.) injections of MDL28170 (10 mg/kg/d for 8 d, beginning 10 min after injury), which readily crosses the blood-brain barrier 22 , reduced the ~120-kDa band by 45 ± 6% (P < 0.001; Fig. 3d,e) , as compared to vehicle-injected controls with SCI, but did not affect the ~250-kDa band (P > 0.05; Fig. 3d ,e), such that the relative proportions of the full-length and cleaved α-subunits were reversed (Fig. 3f) .
We performed voltage-clamp recordings to examine the biophysical properties of I NaP in lumbar motoneurons. In response to slow voltage ramps, lumbar motoneurons displayed a large inward current (Fig. 3g) , which we attributed to I NaP because it was abolished by the known I NaP inhibitors riluzole (5-10 µM) 14 and tetrodotoxin (TTX) (1 µM; Supplementary Fig. 2 ). SCI resulted in an upregulation of I NaP (Fig. 3g )-characterized by a negative shift of the activation threshold-as well as an increase in both the absolute I NaP current and the I NaP current density, as compared to sham-operated controls (P < 0.001; Fig. 3h ). Chronic treatment of neonatal SCI-model rats with MDL28170 reduced the amplitude (P < 0.001; Fig. 3g,h ) and the density of I NaP , as compared to rats with vehicle-treated SCI (P < 0.05; Fig. 3h ). Note that the biophysical properties of I NaP recorded from motoneurons in sham-operated controls were similar in both untreated and MDL28170-treated animals ( Supplementary Fig. 3 ).
Because our data suggested that the expression of Nav1.6, the major Nav channel isoform in motoneurons, is altered after SCI, we then specifically investigated calpain-mediated changes in the I NaP that is mediated by Nav1.6 channels expressed in HEK293 cells. npg Intracellular dialysis of active calpain (0.25 µg/ml) during voltage-clamp recordings produced a gradual hyperpolarization of the Nav1.6-mediated I NaP activation threshold, which was not observed in untreated cells (P < 0.001; Fig. 3i,j) . Over the same 4-min recording duration, I NaP amplitude increased in calpain-treated cells (P < 0.001; Fig. 3i,j) and was abolished by TTX (1 µM; Fig. 3i ). The biophysical properties of I NaP were stable when calpain was discarded from the intrapipette solution ( Fig. 3j and Supplementary Fig. 4 ).
Blocking I NaP reduces spasms in rats with chronic SCI In awake adult rats with chronic SCI, we evoked hind-limb muscle spasms by stimulation of the tibial nerve, while simultaneously taking electromyography (EMG) recordings from the flexor digitorum brevis muscle. Responses were typically characterized by an intense muscle contraction, and were often followed by the self-sustained activity of motor units, with a mean discharge rate of 14 ± 1.6 Hz (Fig. 4a-c) . Nearly half of the motor units (13 of 28) fired below 10 Hz, a slow discharge thought to be driven by I NaP (refs. 4,8,9,23-25) . Next, we monitored muscle spasms in the same rats with SCI both before and after the administration of riluzole, which is known to inhibit I NaP (ref. 26) . The initial muscle spasms were significantly reduced 60 min after a single i.p. injection of riluzole (8 mg/kg; P < 0.05; Fig. 4a-c) , and self-sustained activity of the motor units dropped in number to six, with a firing frequency above 10 Hz (21.2 ± 3.1 Hz). The effect was specific to long-lasting tonic activity, because the M wave and the monosynaptic Hoffmann reflex (H reflex) were not affected (P > 0.05; Fig. 4a insets and Supplementary Table 1) . We also monitored muscle spasms before and after chronic treatment with riluzole for 2 weeks in the same rats with SCI (beginning 30-90 d after injury). Although a low-dose riluzole treatment (2 × 1 mg/kg/d; i.p.) had no effect (P > 0.05; Fig. 4d-f) , rats treated with a higher dose Table 1 ). In high-dose riluzole-treated rats, very few motor units (n = 3) continued to spike at a rate lower than 10 Hz. This beneficial effect was temporary; muscle spasms reappeared 2 weeks after the discontinuation of the chronic treatment (Supplementary Fig. 5 ).
Calpain inhibition prevents cleavage and reduces spasms in rats with chronic SCI Finally, we investigated the effect of chronic treatment with MDL28170 in adult rats with chronic SCI. The animals were injected with MDL28170 (10 mg/kg/d; i.p.) or vehicle solution daily for 10 d, beginning 30-60 d after SCI. Such treatment reduced the cleavage of Nav (Fig. 5a ), which we confirmed by the presence of a lower relative proportion of the ~120-kDa band in MDL28170-treated rats with SCI, as compared to vehicle-treated controls (P < 0.01; Fig. 5b ).
The proportion of total Nav protein represented by the ~120-kDa band was smaller than that represented by the ~250-kDa band in MDL28170-treated rats with SCI, whereas the 120-kDa and ~250-kDa bands were found to represent roughly equal proportions in the vehicle-treated SCI control group (P < 0.01; Fig. 5c ). Furthermore, EMG responses recorded from the flexor digitorum brevis muscle were markedly reduced, as compared to those measured before treatment with MDL28170 in the same animals (P < 0.01; Fig. 5d-f) , whereas the M wave and H reflex were not affected (Supplementary Table 2 ). Chronic treatment with the vehicle did not change EMG responses (Supplementary Fig. 6 ). Remarkably, an additional reduction of EMG responses was observed after a single administration of riluzole (8 mg/kg; i.p.) in animals chronically treated with MDL28170 (P < 0.05; Supplementary Fig. 7) . The long-lasting beneficial effect of chronic MDL28170 treatment was then tested on another set of animals (Fig. 6) . Three weeks after the discontinuation of the 10 d treatment ('wash' animals), cleavage of Nav remained low (Fig. 6a) , and the ~120-kDa band was similar to that observed at the end of the chronic treatment (P > 0.05; Fig. 6b ) and remained much smaller than the ~250-kDa band (P < 0.01; Fig. 6c) . Similarly, muscle spasms quantified at the end of the chronic treatment remained at similar levels when assayed 3 weeks later (P > 0.05; Fig. 6d-f) , and they were markedly reduced, as compared to those measured before treatment in the same animals (P < 0.05; Fig. 6d-f) . Finally, when we considered all rats for which both spasms and proteolysis had been assessed, a significant correlation was found between both parameters (P < 0.01; Supplementary  Fig. 8); i.e., rats with spasticity were those in which a prominent ~120-kDa band was expressed.
DISCUSSION
Here we demonstrate for the first time a long-lasting cleavage of Nav channels in the spinal cord after SCI, and we identify calpain as the factor responsible for this proteolysis. Proteolysis of Nav channels is associated with an upregulation of I NaP in lumbar motoneurons. A clear relationship between these two events is given by our studies on HEK293 cells that express Nav1.6 channels, in which calpain-mediated cleavage of Nav1.6 was found to upregulate I NaP . A similar relationship has been pointed out for epithelial sodium channels (ENaC) 27 . Indeed, the co-expression of a serine protease with ENaC in Xenopus oocytes increases the basal activity of the sodium channel by two-to threefold 28 . The tight relationship between the functionality of the channel and its proteolysis is further supported by the observation that internal perfusion of voltage-clamped squid axons with the proteolytic enzyme pronase prevents the inactivation of the sodium conductance and generates a pronounced I NaP (ref. 29) . Lastly, calpain inhibition decreases the late sodium current in ventricular cardiomyocytes that is associated with chronic heart failure 30 . We observed a similar effect in our study: MDL28170 treatment after SCI limited the enhancement of I NaP in motoneurons. However, the rescue was partial, suggesting the existence of calpainindependent mechanism(s) involved in I NaP upregulation. Given that the activation of 5-HT 2 receptors upregulates the I NaP (ref. 4) , the constitutive activation of 5-HT 2 receptors after SCI 10 might be one of these mechanisms. The Ca 2+ PIC of motoneurons is also facilitated by 5-HT 2 receptors 31 and their constitutive activity after SCI 10 . Because of the low Ca 2+ -buffering capacity of motoneurons 32 , an increase in the magnitude of the Ca 2+ PIC might activate Ca 2+ -dependent calpains. Then, calpains upregulate I NaP not only by increasing its magnitude, but also by hyperpolarizing its activation threshold, such as has been reported in sacral motoneurons from adult rats with chronic SCI 24 . The enhancement of the I NaP in turn increases the excitability of motoneurons 15 by facilitating: 1) the spike initiation npg during slowly rising inputs 33 ; 2) the related, sub-threshold membrane oscillations at the source of a slow, self-sustained spiking activity, which is associated with abnormally slow firing of motor units recorded in humans with spasticity 4, 8, 9, [23] [24] [25] ; and 3) the recruitment of the high-threshold Ca 2+ PIC 8, 15 that ultimately leads to the selfsustained firing associated with intense muscle spasms 8, 9 . In this context, riluzole reduces spasticity by decoupling the tandem relationship of I NaP and Ca 2+ PIC. Calpain proteolyzes the Nav1.2 α-subunit after a traumatic brain injury 19, 34 . Proteolyzed Nav channels remain in the plasma membrane 19 and might account for the substantial increase seen in the expression of Nav1.6 channels in the AISs of motoneurons after SCI. Motoneurons alone are unlikely to account for all of the changes in the expression of Nav channels located below the lesion. Whereas no changes occur in Renshaw cells, increases in the expression of both Nav1.6 channels in the lumbar white matter 35 and Nav1.3 channels in dorsal horn neurons 36 have been described after SCI. Similarly, increases in the expression of Nav1.6 channels in microglia 37 might also arise after SCI. Calpain probably proteolyses other substrates, in addition to Nav channels. Expression of the potassium-chloride co-transporter KCC2 was shown to be downregulated in motoneurons after SCI and to cause a net disinhibition, thereby contributing to the generation of spasticity 3 . It is worth mentioning that the C-terminal domain of KCC2 is sensitive to calpain, which alters its ability to extrude Cl -ions 38 . This leads us to consider the possibility that a proteolytic cleavage of both the Nav channels and KCC2 may compose the upstream mechanism of spasticity.
Calpains exist as two major isoforms, µ-calpain (or calpain 1) and m-calpain (or calpain 2), that differ from each other in the range of Ca 2+ concentrations that they require for half-maximal activation (µM and mM ranges, respectively). The expression level of calpain markedly increases a few hours after SCI [39] [40] [41] [42] , especially in motoneurons 43 . The activation of calpain 1, but not of calpain 2, contributes to initial reactive gliosis and tissue damage after SCI 40, 44, 45 , but calpain activity is confined to the injury site 46 . In regard to the calpain-mediated upregulation of I NaP , this observation is compatible with the small I NaP recorded in sacral motoneurons after acute SCI 24 . Although the increased expression of calpain during the acute phase of injury is well documented, very little is known about its expression during the chronic phase. However, global gene expression, as measured through laser capture of mRNA in sacral motoneurons below the SCI, showed differentially expressed genes encoding calpastatin (a natural inhibitor of calpains) and calpain 1 (ref. 47) . In particular, expression of the gene encoding calpastatin decreases 21 d after SCI, whereas the gene encoding calpain 1 increases its expression 60 d after SCI. These data fit with a gradual activation of calpains in the spinal cord, in parallel with both the proteolytic cleavage of Nav channels and the emergence of spasticity in hind limbs. The isoform of calpain that is involved in the chronic phase of SCI should be investigated further in the future. It is worth mentioning that the expression of calpain 1, but not of calpain 2, was shown to be increased in the dorsal horn of the spinal cord 3-4 weeks after peripheral nerve ligation 38 .
The present study opens up new avenues for the treatment of spasticity after SCI. These strategies would consist of targeting I NaP or the upstream mechanism, calpain-mediated proteolysis of Nav channels. The magnitude of I NaP can be decreased by riluzole, which is currently licensed for the symptomatic treatment of amyotrophic lateral sclerosis (ALS). The therapeutic potential of riluzole has long been considered to be related mainly to an antiglutamatergic action 48 . However, the administration of riluzole reduced muscle spasms in rats with SCI, without affecting the H reflex that results from the activation of glutamatergic I a afferents, thereby demonstrating that the antiglutamatergic action of this drug could not account for the observed effects. The observed effect of riluzole probably results from an inhibition of I NaP 11,14 , a current that was shown to be upregulated and to contribute to reflex hyperexcitability in the chronic phase of SCI in both rats 8 and humans 49 . In line with this assumption, the slow motor-unit activity ascribed to the regenerative activation of I NaP 4, 8, 9, [23] [24] [25] 50 is almost silenced by riluzole. In further support of a role for riluzole in reducing spasticity, a dose of 8 mg/kg decreases the response of the tail muscles to cutaneous stimuli in rats with SCI at the sacral level 51 . Similarly, after SCI, I NaP is upregulated in dorsal horn neurons 52 , and riluzole reduces neuropathic pain in rats with SCI 53 . All together, these data provide strong preclinical evidence for the translation of this treatment to humans during the chronic stage of SCI, a process that will probably be facilitated by a major clinical trial that is currently in progress to test the neuroprotective effects of riluzole in the acute phase of SCI 54 .
Proteases, and particularly calpains, represent important pharmacological targets for the treatment of different human pathologies 55 . In the present study, the use of MDL28170 demonstrates the potential benefits of calpain-specific therapies for the treatment of spasticity. Similarly, a single intraspinal microinjection of MDL28170 after SCI markedly improves both locomotion and pathological outcome 56 . One caveat to the specificity of MDL28170 is its activity against the lysosomal cysteine protease cathepsin B, although MDL28170 provides a 2.5-fold better affinity for calpains than for cathepsin B (refs. 57,58). A predominant effect of MDL28170 on calpains can be predicted, given that a minimal systemic dose of MDL28170 was used to reduce cysteine proteinase activity in the central nervous system (CNS) 22, 20 and that inhibitors targeting cathepsin B do not prevent the cleavage of sodium channels 19 . In line with this, calpain inhibition with genetic tools provides neuroprotection in the acute phase of injuries 44 .
The other major result of the present study is that even when transient treatment with a calpain inhibitor starts only after spasticity has been established, spasms can still be reduced for a long-lasting period. The post-injury administration of calpain inhibitors for a short period seems to be a rational and feasible treatment for spasticity induced by SCI, without being detrimental to the physiological functions of calpains 59 over a long period of time. Because the co-administration of riluzole with MDL28170 further reduced muscle spasms, a transient inhibition of calpain, followed by a chronic blockade of I NaP , might be even more efficient than either given alone for a functional recovery after SCI.
METHODS
Methods and any associated references are available in the online version of the paper. 
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